GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Total Equity

Cresco Labs (Cresco Labs) Total Equity : $420.0 Mil (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Total Equity?

Cresco Labs's total equity for the quarter that ended in Mar. 2024 was $420.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cresco Labs Total Equity Historical Data

The historical data trend for Cresco Labs's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Total Equity Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 322.62 575.33 797.74 587.68 428.07

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 567.38 546.98 425.86 428.07 419.97

Cresco Labs Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cresco Labs's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1358.467-930.4
=428.1

Cresco Labs's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1360.065-940.093
=420.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Total Equity Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs (Cresco Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Total Equity
Comparable Companies
TSX:DHT.U NEOE:GLAS.A.U TSX:WEED TSX:TSND TSX:GUD TSX:CRON TSX:ACB XCNQ:AAWH.U XCNQ:AYR.A TSX:OGI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
6CQ:Germany CL:Canada
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Website
https://www.crescolabs.com
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.